PharmaForce Conference
September 18-September 20, 2017
Hilton Austin, TX
PharmaTimes: News RSS
- GSK’s Nucala approved in the US for hypereosinophilic syndrome
- Sosei Heptares scores $5m milestone payment from Pfizer
- Novel nasal spray reduces COVID-19 viral replication in animal study
- Novacyt signs deal with UK government for COVID-19 testing kits
- Accenture reveals data science project for paediatric leukaemia
- ABPI and EFPIA call for medicines prioritisation in UK/EU trade talks
- Gilead’s oral JAK inhibitor filgotinib wins EU approval
- First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
- Monte Rosa Therapeutics raises $96m to develop protein-degrading molecules
- UK consumers seeking advice from pharmacists during pandemic, research finds
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish